Status:
UNKNOWN
Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
BioGenesis
Conditions:
Pregnancy Outcome After In Vitro Fertilization (IVF)
Eligibility:
FEMALE
21-39 years
Phase:
PHASE4
Brief Summary
The aim is to explore whether the incidence of progesterone rise in the late follicular phase differs between GnRH-agonist and GnRH-antagonist protocols for IVF and whether this has an impact on the p...
Detailed Description
In view of the current debate concerning possible differences in efficacy between the two GnRH analogues, the current study aimed to explore whether progesterone control in the late follicular phase d...
Eligibility Criteria
Inclusion
- age \< 39
- follicle-stimulating hormone (FSH) \< 12
- gonadotropin dose 100-300IU
Exclusion
- endometriosis
- known endocrine disorder
- blood analyzed in another laboratory
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01191710
Start Date
January 1 2007
End Date
January 1 2011
Last Update
September 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biogenesis
Thessaloniki, Pylaia, Greece, 55536